Optimization of regimen of adjuvant interferonotherapy in patients with renal cell carcinoma

Optimization of regimen of adjuvant interferonotherapy in 55 patients with locally advanced renal cell carcinoma on the basis of results of cellular sensitivity analysis of neutrophils to reaferon in vitro was carried out. The comparative analysis showed, that the optimization of regimen of adjuvant reaferonotherapy allowed to carry out more adequate immunorehabilitation in patients, to reduce toxicity of treatment, and also to increase efficiency of the combined treatment in patients with renal cell carcinoma.